Moody’s revises The Queens Health System’s outlook to negative

Moody’s Investors Service affirmed its “A1” and “A1/ P-1” ratings on Honolulu-based The Queen’s Health Systems’ revenue bonds, affecting $392 million of debt.

Advertisement

The affirmation is a result of several factors, including the health system’s strong liquidity, diverse revenue streams, dominant market position and strong reputation. Moody’s also acknowledged the health system’s variable operating performance and limited debt coverage.

The outlook was revised to negative from stable, reflecting the health system’s sizable losses, which totaled $65 million in fiscal 2017.  

More articles on healthcare finance:
10 hospitals seeking RCM talent
Microwize Technology releases RCM services
Kentucky hospital at risk of losing Medicare funding

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.